Invited Faculty
Mark W. Burket, MD
The University of Toledo
USA
| Date |
Time |
Place |
Session / Title |
Role |
| April 25 |
8:35 AM - 9:30 AM |
Endovascular Theater, Level 1 |
Live Case Session I |
Moderator |
| April 25 |
9:30 AM - 9:40 AM |
Endovascular Theater, Level 1 |
Endovascular Session I. Changing Paradigm and Future Concepts in Peripheral Intervention: Iliac to SFA
DES vs. DCB: When to Choose? |
Lecturer |
| April 25 |
9:30 AM - 10:30 AM |
Endovascular Theater, Level 1 |
Endovascular Session I. Changing Paradigm and Future Concepts in Peripheral Intervention: Iliac to SFA |
Panelist |
| April 25 |
2:00 PM - 3:00 PM |
Asan Medical Center, Seoul, Korea |
Live Case Session III. BTK Intervention
Asan Medical Center, Seoul, Korea: Case #6 |
1st Operator |
| April 25 |
4:00 PM - 5:00 PM |
Endovascular Theater, Level 1 |
Live Case Session IV. SFA Intervention |
Discussant |
| April 25 |
5:00 PM - 5:40 PM |
Endovascular Theater, Level 1 |
Endovascular Session IV. Carotid Intervention |
Moderator |
| April 25 |
5:00 PM - 5:08 PM |
Endovascular Theater, Level 1 |
Endovascular Session IV. Carotid Intervention
Where Are We Now? Current Scientific Evidences from Clinical Trials and Upcoming New Horizon |
Lecturer |
| April 26 |
7:00 AM - 8:10 AM |
Valve Theater, Level 1 |
Peripheral Vascular Intervention |
Panelist |
| April 26 |
10:00 AM - 11:15 AM |
Valve Theater, Level 1 |
VIVA Highlights @ TCTAP 2017 |
Panelist |
| April 26 |
11:15 AM - 11:25 AM |
Valve Theater, Level 1 |
VIVA Highlights @ TCTAP 2017
Prognosis of the CLI patient - From Olive to Wifi |
Lecturer |
| April 26 |
11:15 AM - 12:30 PM |
Valve Theater, Level 1 |
VIVA Highlights @ TCTAP 2017 |
Moderator |
| April 26 |
11:25 AM - 11:35 AM |
Valve Theater, Level 1 |
VIVA Highlights @ TCTAP 2017
The Modern Endovascular Approach to Infrapopliteal Occlusive Disease |
Lecturer |
| April 26 |
3:30 PM - 4:30 PM |
Abstract Zone II, Level 3 |
2-5. Endovascular Intervention |
Moderator |
| April 27 |
4:40 PM - 5:40 PM |
Room 105, Level 1 |
II-3. Endovascular Intervention |
Moderator |
